Aller au contenu principal

 Articles scientifiques

Single-access laparoscopic primary and incisional prosthetic hernia repair: first 50 patients.

Auteurs : Dapri G, Bruyns J, Paesmans M, Himpens J, Cadière GB
Année : 2013
Journal : Hernia
Volume : 17(5)
Pages : 619-26

The lung cancer patient at the emergency department: A three-year retrospective study.

Auteurs : Gorham J, Ameye L, Berghmans T, Sculier JP, Meert AP
Année : 2013
Journal : Lung Cancer
Volume : 80(2)
Pages : 203-8.

Oral Antibiotics for Fever in Low-Risk Neutropenic Patients With Cancer: A Double-Blind, Randomized, Multicenter Trial Comparing Single Daily Moxifloxacin With Twice Daily Ciprofloxacin Plus Amoxicillin/Clavulanic Acid Combination Therapy--EORTC Infe

Auteurs : Kern WV, Marchetti O, Drgona L, Akan H, Aoun M, Akova M, De Bock R, Paesmans M, Viscoli C, Calandra T
Année : 2013
Journal : J. Clin. Oncol.
Volume : 31(9)
Pages : 1149-56

Non-malignant causes of hypercalcemia in cancer patients: a frequent and neglected occurrence.

Auteurs : Soyfoo MS, Brenner K, Paesmans M, Body JJ
Année : 2013
Journal : Support Care Cancer
Volume : 21(5)
Pages : 1415-19

Prognostic impact of pregnancy after breast cancer according to estrogen receptor status: a multicenter retrospective study.

Auteurs : Azim HA, Kroman N, Paesmans M, Gelber S, Rotmensz N, Ameye L, De Mattos-Arruda L, Pistilli B, Pinto A, Jensen MB, Cordoba O, de Azambuja E, Goldhirsch A, Piccart-Gebhart M, Peccatori FA
Année : 2013
Journal : J. Clin. Oncol.
Volume : 31(1)
Pages : 73-9

Role of the multidisciplinary team in breast cancer management: results from a large international survey involving 39 countries.

Auteurs : Saini KS, Taylor C, Ramirez AJ, Palmieri C, Gunnarsson U, Schmoll HJ, Dolci SM, Ghenne C, Metzger-Filho O, Skrzypski M, Paesmans M, Ameye L, de Azambuja E, Piccart-Gebhart M
Année : 2012
Journal : Ann Oncol
Volume : 23(4)
Pages : 853-859

Surrogate markers predicting overall survival for lung cancer: ELCWP recommendations.

Auteurs : Berghmans T, Pasleau F, Paesmans M, Bonduelle Y, Cadranel J, CsToth I, Garcia C, Giner V, Holbrechts S, Lafitte JJ, Lecomte J, Louviaux I, Markiewicz E, Meert AP, Richez M, Roelandts M, Scherpereel A, Tulippe Ch, Van Houtte P, van Schil P, Wachters C, Westeel V, Sculier JP
Année : 2012
Journal : Eur. Respir. J.
Volume : 39(1)
Pages : 9-28

Serial FDG-PET/CT for early outcome prediction in patients with metastatic colorectal cancer undergoing chemotherapy.

Auteurs : Hendlisz A, Golfinopoulos V, Garcia C, Covas A, Emonts P, Ameye L, Paesmans M, Deleporte A, Machiels G, Toussaint E, Vanderlinden B, Awada A, Piccart-Gebhart M, Flamen P
Année : 2012
Journal : Ann Oncol
Volume : 23(7)
Pages : 1687-93

Safety and Efficacy of Radioimmunotherapy with 90Yttrium-rituximab in Patients with Relapsed CD20+ B cell Lymphoma: A Feasibility Study

Auteurs : Vaes M, Bron D, Vugts DJ, Paesmans M, Meuleman N, Ghanem G, Vanderlinden B, Thielemans K, van Dongen GA, Flamen P, Muylle K
Année : 2012
Journal : J Cancer Sci Ther
Volume : 4(12)
Pages : 394-400

A phase II randomized study of combined infusional leucovorin sodium and 5- FU versus the leucovorin calcium followed by 5-FU both in combination with irinotecan or oxaliplatin in patients with metastatic colorectal cancer.

Auteurs : Bleiberg H, Vandebroek A, Deleu I, Vergauwe P, Rezaei Kalantari H, DHaens G, Paesmans M, Peeters M, Efira A, Humblet Y
Année : 2012
Journal : Acta Gastroenterol Belg
Volume : 75(1)
Pages : 14-21

Update of the evolution of breast cancer incidence in relation to hormone replacement therapy use in Belgium.

Auteurs : Antoine C, Ameye L, Paesmans M, Rozenberg S
Année : 2012
Journal : Maturitas
Volume : 72(4)
Pages : 317-23

Bevacizumab and Breast Cancer: A Meta-Analysis of First-Line Phase III Studies and a Critical Reappraisal of Available Evidence.

Auteurs : Rossari JR, Metzger-Filho O, Paesmans M, Saini KS, Gennari A, de Azambuja E, Piccart-Gebhart M
Année : 2012
Journal : J Oncol
Volume : 2012
Pages : 417673

Final results and pharmacoeconomic analysis of a trial comparing two neoadjuvant chemotherapy (CT) regimens followed by surgery in patients with resectable non-small cell lung cancer (NSCLC): A phase II randomised study by the European Lung Cancer Wo

Auteurs : Berghmans T, Lafitte JJ, Giner V, Berchier MC, Scherpereel A, Lewin D, Paesmans M, Meert AP, Bosschaerts T, Leclercq N, Sculier JP
Année : 2012
Journal : Lung Cancer
Volume : 77(3)
Pages : 605-610

M-ficolin levels are associated with the occurrence of severe infections in patients with haematological cancer undergoing chemotherapy.

Auteurs : Ameye L, Paesmans M, Thiel S, Jensenius JC, Aoun M
Année : 2012
Journal : Clin. Exp. Immunol.
Volume : 167(2)
Pages : 303-8

Therapeutic drug monitoring of posaconazole in patients with acute myeloid leukemia or myelodysplasic syndrome: a bicentric study.

Auteurs : Vaes M, Hites M, Cotton F, Bourguignon AM, Csergo M, Rasson C, Ameye L, Bron D, Jacobs F, Aoun M
Année : 2012
Journal : Antimicrob. Agents Chemother.
Volume : 56(12))
Pages : 6298-303

The relationship between heart rate variability and time-course of carcinoembryonic antigen in colorectal cancer.

Auteurs : Mouton C, Ronson A, Razavi D, Delhaye F, Kupper N, Paesmans M, Moreau M, Nogaret JM, Hendlisz A, Gidron Y
Année : 2012
Journal : Auton Neurosci
Volume : 166(1-2)
Pages : 96-9

Neoadjuvant anthracycline and trastuzumab for breast cancer: is concurrent treatment safe?

Auteurs : Bozovic-Spasojevic I, Azim HA, Paesmans M, Suter T, Piccart-Gebhart M, de Azambuja E
Année : 2011
Journal : Lancet Oncol
Volume : 12(3)
Pages : 209-11

Invasive mechanical ventilation in cancer patients. Prior non invasive ventilation is a poor prognostic factor.

Auteurs : Meert AP, Berghmans T, Markiewicz E, Hardy M, Nayer N, Paesmans M, Sculier JP
Année : 2011
Journal : J BUON
Volume : 16(1)
Pages : 160-5

C-erbB-3 expression in non-small cell lung cancer (NSCLC) patients treated by Erlotinib.

Auteurs : CsToth I, Anthoine G, Berghmans T, Mascaux C, Paesmans M, Sculier JP, Meert AP
Année : 2011
Journal : Anticancer Res
Volume : 31(1)
Pages : 281-5

Prognostic factors in stage III non-small cell lung cancer: a review of conventional, metabolic and new biological variables.

Auteurs : Berghmans T, Paesmans M, Sculier JP
Année : 2011
Journal : Ther Adv Med Oncol
Volume : 3(3)
Pages : 127-38